Document is current
Any future updates will be listed below
-
Authors
Tsuji, Daiki https://orcid.org/0000-0001-8894-2841
Matsumoto, Megumi
Kawasaki, Yohei
Kim, Yong-I. L.
Yamamoto, Keisuke
Nakamichi, Hidenori
Sahara, Yuri
Makuta, Ryo
Yokoi, Mari
Miyagi, Takehiro
Itoh, Kunihiko
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science
University of Shizuoka academic research grant
- License Information
-
More Information
Article History
Received: 20 July 2020
Accepted: 9 October 2020
First Online: 24 October 2020
Compliance with ethical standards
:
: D.T. reports personal fees from Nippon Kayaku Co., Ltd., personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Kyowa Hakko Kirin Co., Ltd., outside the submitted work, K.Y. reports personal fees from Sumitomo Dainippon Pharma Co., Ltd, personal fees from Kowa Pharmaceutical Co., Ltd., personal fees from DAIICHI SANKYO COMPANY, LIMITED, personal fees from Nippon Boehringer Ingelheim Co., Led, outside the submitted work, and H. N. reports personal fees from Yakult Honsha Co., Ltd, personal fees from Takeda Pharmaceutical Company Ltd., personal fees from AstraZeneca K.K., outside the submitted work;. All remaining authors have declared no conflicts of interest.
: This study was conducted in accordance with Ethical Guidelines for Medical and Health Research Involving Human Subjects published by Japan’s Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare, Japan and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the institutional review board at Seirei Hamamatsu General Hospital.
: Written informed consent was obtained from all participants.
